Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281 to 7.237), disease duration (OR = 1.068, 95%CI 1.026 to 1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243 to 3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986 to 17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756 to 6.826), male sex (OR = 0.399, 95%CI 0.229 to 0.686).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025.

Source: Abstract.

Patients were randomly divided into training (n = 447) and validation (n = 192) sets at a 7:3 ratio.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis

Cohort study · Frontiers in Medicine · 2026

Original publication title

Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis

Zhilong Wang; Zhiyou Zhou; Ruichen Jiang; Haoning Ma; Yanzhu Shen; Xiangsheng Tang; Ping Yi; Yi Li; Zihan Wei

Copyright © 2026 Wang, Zhou, Jiang, Ma, Shen, Tang, Yi, Li and Wei.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis.

Source: Background

Abstract: What methods does the paper describe?

A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training (n = 447) and validation (n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T-score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA).

Source: Methods

Abstract: Results

The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281 to 7.237), disease duration (OR = 1.068, 95%CI 1.026 to 1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243 to 3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986 to 17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756 to 6.826), male sex (OR = 0.399, 95%CI 0.229 to 0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities.

DCA confirmed the clinical utility of the model.

Source: Results

Abstract: Conclusion

We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.

Source: Conclusion
Authors’ abstract

Background

Psoriasis is a chronic inflammatory disease associated with increased risk of osteoporosis. However, practical tools for identifying high-risk patients in clinical settings remain limited. This study aimed to develop and validate a nomogram for predicting osteoporosis in patients with psoriasis.

Methods

A retrospective cohort study was conducted including 639 psoriasis patients from January 2023 to October 2025. Patients were randomly divided into training (n = 447) and validation (n = 192) sets at a 7:3 ratio. Osteoporosis was defined as dual-energy X-ray absorptiometry (DXA) T-score ≤−2.5. Univariate analysis and multivariate logistic regression were performed to identify independent risk factors. A nomogram was constructed based on the final model and evaluated using C-index, calibration curves, and decision curve analysis (DCA).

Results

The overall prevalence of osteoporosis was 11.7% (75/639). Six independent risk factors were identified: advanced age (OR = 4.054, 95%CI 2.281 to 7.237), disease duration (OR = 1.068, 95%CI 1.026 to 1.11), psoriatic arthritis (OR = 2.178, 95%CI 1.243 to 3.796), vitamin D deficiency (OR = 5.148, 95%CI 1.986 to 17.672), systemic corticosteroid use (OR = 3.501, 95%CI 1.756 to 6.826), male sex (OR = 0.399, 95%CI 0.229 to 0.686). The nomogram demonstrated good discrimination with AUC of 0.824 in the training set and 0.771 in the validation set. Calibration curves showed excellent agreement between predicted and observed probabilities.

DCA confirmed the clinical utility of the model.

Conclusion

We developed and validated a practical nomogram incorporating psoriasis-specific and traditional risk factors for predicting osteoporosis risk. This tool may facilitate early identification of high-risk patients and guide clinical decision-making for DXA screening and preventive interventions.

Publication and source details

Original title: Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis

Zhilong Wang; Zhiyou Zhou; Ruichen Jiang; Haoning Ma; Yanzhu Shen; Xiangsheng Tang; Ping Yi; Yi Li; Zihan Wei

Frontiers in Medicine · 2026

* Correspondence: Ping Yi, CJFH_YPSpine@163.com; Yi Li, liyi_doc@163.com; Zihan Wei, weizihan@pku.edu.cn
†

These authors have contributed equally to this work and share first authorship

Copyright © 2026 Wang, Zhou, Jiang, Ma, Shen, Tang, Yi, Li and Wei.2026Wang, Zhou, Jiang, Ma, Shen, Tang, Yi, Li and Weihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National High Level Hospital Clinical Research Funding and the Elite Medical Professionals Initiative of China-Japan Friendship Hospital (No. ZRJY2025-QMPY26).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:08:12.890974+00:00

DOI: 10.3389/fmed.2026.1826823 · PMC13395702